About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06923254

7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).

Lead sponsor: Chinese PLA General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jing Tang

CONTACT

+8618001184224 jessietang301@163.com

Sponsors

Lead Sponsor

Chinese PLA General Hospital

In this study, we analyzed the imaging characteristics of HE. First, with the advantages of 7TMRI, we analyzed the differences in imaging characteristics between HE patients and the healthy, including brain functional imaging and structural imaging. Second, we analyzed the differences in imaging characteristics between different subgroups of HE patients. Finally, we analyzed the correlation between the prognostic results of HE patients after follow-up and the imaging characteristics.

Age

18 - 89 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level.
•Regular follow-up.

Exclusion Criteria

•Contraindications to MRI.
•Patients with cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease.

Related studies

RECRUITINGPhase 2

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

NCT05982496 · Breast Cancer Female, Lobular Breast Carcinoma, and more

Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management

NCT06755697 · Knee Osteoarthritis, Glucose, and more

ETASCAN Project: ETAS Project 2

NCT07550140 · Cognition, Affect (Mental Function), and more

Optimizing Liver MRI Using Breath-Holding With and Without Oxygen

NCT07135401 · MRI, MRI Image Enhancement

New Care Pathway Using Automated Dynamic Laximetry

NCT07028476 · Knee Sprain, Automated Dynamic Laximetry (ADL), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 11, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment200

Start dateApr 2025

Last updatedApr 11, 2025

Condition

Hepatic Encephalopathy (HE)MRI fMRI Research

Locations shown

Chinese PLA General Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions